- Home
- WKC vs CLDX Comparison
WKC vs CLDX Comparison
Compare WKC & CLDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WKC
- CLDX
- Stock Information
- Founded
- WKC 1984
- CLDX N/A
- Country
- WKC United States
- CLDX United States
- Employees
- WKC N/A
- CLDX N/A
- Industry
- WKC Oil Refining/Marketing
- CLDX Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- WKC Energy
- CLDX Health Care
- Exchange
- WKC Nasdaq
- CLDX Nasdaq
- Market Cap
- WKC 1.6B
- CLDX 1.3B
- IPO Year
- WKC N/A
- CLDX 2008
- Fundamental
- Price
- WKC $28.35
- CLDX $22.79
- Analyst Decision
- WKC Sell
- CLDX Buy
- Analyst Count
- WKC 4
- CLDX 9
- Target Price
- WKC $29.00
- CLDX $50.00
- AVG Volume (30 Days)
- WKC 506.8K
- CLDX 1.0M
- Earning Date
- WKC 07-31-2025
- CLDX 08-07-2025
- Dividend Yield
- WKC 2.82%
- CLDX N/A
- EPS Growth
- WKC N/A
- CLDX N/A
- EPS
- WKC 0.32
- CLDX N/A
- Revenue
- WKC $40,669,100,000.00
- CLDX $7,559,000.00
- Revenue This Year
- WKC N/A
- CLDX N/A
- Revenue Next Year
- WKC $1.84
- CLDX N/A
- P/E Ratio
- WKC $87.31
- CLDX N/A
- Revenue Growth
- WKC N/A
- CLDX 24.49
- 52 Week Low
- WKC $22.71
- CLDX $14.40
- 52 Week High
- WKC $31.71
- CLDX $47.00
- Technical
- Relative Strength Index (RSI)
- WKC 48.76
- CLDX 58.63
- Support Level
- WKC $27.95
- CLDX $21.71
- Resistance Level
- WKC $28.76
- CLDX $23.85
- Average True Range (ATR)
- WKC 0.48
- CLDX 1.11
- MACD
- WKC -0.12
- CLDX 0.03
- Stochastic Oscillator
- WKC 22.32
- CLDX 74.66
About WKC World Kinect Corporation
World Kinect Corp is an energy management company involved in providing supply fulfillment, energy procurement advisory services, and transaction and payment management solutions to commercial and industrial customers. It sells and delivers liquid fuels, natural gas, electricity, renewable energy, and other sustainability solutions. The company operates in three reportable segments consisting of aviation, land, and marine. The company earns the majority of its revenue from the Aviation segment.
About CLDX Celldex Therapeutics Inc.
Celldex Therapeutics Inc is a biopharmaceutical company. It is focused on the development and commercialization of several immunotherapy technologies and other cancer-targeting biologics. The company is also engaged in clinical trials for products targeting breast cancer, metastatic melanoma, lung cancer, solid tumors, and ovarian cancer. It has single operating and reportable segment that operates in the business of development, manufacturing and commercialization of novel therapeutics for human health care.